Antimicrobial Strategies against Oral Pathogenic Bacteria and Biofilm, 2nd Edition

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiofilm Strategies".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 5738

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medicine, Faculty of Medicine, University Complutense of Madrid, Madrid, Spain
Interests: microbiology; bacterial biofilms; oral pathogens; genomics; metabolomics; cell biology; development of new antimicrobial agents; mechanisms of antibiotic resistance
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue is a continuation of our previous Special Issue on the same topic entitled Oral Pathogenic Bacteria Infection Control

In the oral cavity, microbial homeostasis and its maintenance represent a great global challenge. Microorganisms in this niche are organized in groups of multiple species, that is, in biofilms. Nowadays, the characterization of the species diversity of these communities is advancing rapidly through next-generation sequencing; however, we must not forget their functionality, knowledge that advances more slowly with regard to their metabolic properties and the flows of substrates and products, which increasingly reveal microbial taxa of unknown but key functions in the development of oral disease. The alteration of the balance in the oral cavity, and, therefore, the dysbiosis of the microbial community present in its different locations, constitute an important factor in determining the virulence of the microbial consortium and the consequent development of oral infectious diseases, including dental caries, gingivitis, periodontitis, endodontic periapical lesions, and peri-implantitis.

The effective management of oral infectious diseases related to biofilms is a challenge with multiple approaches that must continue to develop, ranging from the precise and continuous elimination of specific oral pathogens to the use of antimicrobial agent release, contact-killing, and multi-functional strategies for the prevention of initial bacterial attachment or biofilm dispersal. Much remains to be investigated about the reasons for the emergence of specific organisms, changes in relative abundances, their interdependence between species, their fitness or their adaptations related to oral diseases. Likewise, the use of probiotics and compounds that modulate the virulence of the oral biofilm without killing commensal bacteria and the application of novel approaches such as nanomaterials, quaternary ammonium salts, arginine or natural products, avoiding the elimination of commensals that can cause ecological dysbiosis, are presented as powerful preventive tools. Antimicrobial photodynamic therapy or cold atmospheric plasma application has also emerged as an alternative to antimicrobial treatments and biofilm disruption.

This Special Issue aims to gather papers describing innovative antimicrobial strategies with the potential to control infections related to oral biofilms with special interest in those capable of inhibiting biofilm virulence without necessarily inducing the microbial dysbiosis of oral biofilms. Also, papers are requested to improve our knowledge of the metabolic properties and the fluxes of substrates and products that occur in these oral microbial communities related to the development of the diseases. These methods can be used in the near future to effectively promote the clinical management of infectious oral diseases, and thus benefit oral health in the face of the increasing emergence of antibiotic-resistant bacteria.

After the successful first volume on Oral Pathogenic Bacteria Infection Control, and considering the great challenges that these infections entail, we are delighted to launch a second volume, in which we hope to bring together the new advances in this exciting topic. We kindly invite you to submit original research articles as well as review articles.

Prof. Dr. María C. Sánchez Beltrán
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oral biofilms
  • oral pathogenic bacteria
  • oral infections
  • antimicrobial strategies
  • microbial oral homeostasis
  • oral dysbiosis
  • antibiotic resistance

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Related Special Issue

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 3728 KiB  
Article
Illumina Sequencing in Conjunction with Propidium Monoazide to Identify Live Bacteria After Antiseptic Treatment in a Complex Oral Biofilm: A Study Using an Ex Vivo Supragingival Biofilm Model
by María C. Sánchez, Paola Hernández, Ángela Velapatiño, Eber Cuba, María J. Ciudad and Luis Collado
Antibiotics 2024, 13(11), 1000; https://doi.org/10.3390/antibiotics13111000 - 23 Oct 2024
Viewed by 618
Abstract
Background/Objectives: The evaluation of the efficacy of antibacterial treatments in complex oral ecosystems is limited by the inability to differentiate live from dead bacteria using omic techniques. The objective of this study was therefore to assess the ability of the combination of [...] Read more.
Background/Objectives: The evaluation of the efficacy of antibacterial treatments in complex oral ecosystems is limited by the inability to differentiate live from dead bacteria using omic techniques. The objective of this study was therefore to assess the ability of the combination of the 16S rRNA Illumina sequencing methodology and the action of propidium monoazide (PMA) to study viable bacterial profiles in oral biofilms after exposure to an antiseptic compound. Methods: Cariogenic supragingival biofilms were developed in an ex vivo model for 96 h, using saliva from healthy volunteers. The biofilms were treated with 0.12% chlorhexidine (CHX) combined with 0.05% cetylpyridinium chloride (CPC), for 60 s, using phosphate buffered saline as a control. After exposure, each biofilm was treated or not with PMA to then extract the bacterial DNA, quantify it by Qubit, quantify the bacterial population using qPCR, and perform the metataxonomic study of the samples using Illumina 16S rRNA sequencing. Results: A significantly lower DNA concentration in the PMA-treated biofilms (p < 0.05 compared with those not exposed to PMA) was observed. The viable bacterial count obtained by qPCR differed significantly from the total bacterial count in the biofilm samples exposed to the antiseptic (p < 0.05). The viable microbiome differed significantly from the total bacterial profile of the samples treated with CHX/CPC after exposure to PMA (p < 0.05 at the α- and β-diversity levels). Conclusions: The combination of Illumina 16S rRNA sequencing and PMA helps solve the inability to evaluate the efficacy of antibacterial treatments in the bacterial profile of complex ecosystems such as oral biofilms. Full article
Show Figures

Figure 1

16 pages, 2068 KiB  
Article
Comparative Study of Systemic vs. Local Antibiotics with Subgingival Instrumentation in Stage III–IV Periodontitis: A Retrospective Analysis
by Ioana Ilyes, Marius Boariu, Darian Rusu, Vincenzo Iorio-Siciliano, Octavia Vela, Simina Boia, Viorelia Radulescu, Petra Șurlin, Holger Jentsch, Alexandru Lodin and Stefan-Ioan Stratul
Antibiotics 2024, 13(5), 430; https://doi.org/10.3390/antibiotics13050430 - 9 May 2024
Viewed by 1942
Abstract
To improve the clinical and microbiological outcomes of non-surgical mechanical periodontal therapy, the adjunctive use of antimicrobials has been utilized in treating moderate-to-severe periodontitis. In our study, the retrospective design included previously collected health-related patient data, obtained from the printed and digital charts [...] Read more.
To improve the clinical and microbiological outcomes of non-surgical mechanical periodontal therapy, the adjunctive use of antimicrobials has been utilized in treating moderate-to-severe periodontitis. In our study, the retrospective design included previously collected health-related patient data, obtained from the printed and digital charts of patients who received systemic or local antibiotic adjuncts to SI (subgingival instrumentation). A total of 34 patients (diagnosed with generalized Stage III/IV periodontitis) met the inclusion and exclusion criteria and were evaluated. The samples were tested for the following bacterial strains: Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), Porphyromonas gingivalis (P. gingivalis), Prevotella intermedia (P. intermedia), Tanererella forsythia (T. forsythia), and Treponema denticola (T. denticola). The inter-group comparisons of the bacterial species did not show statistically significant differences between groups. The present study aimed to evaluate the clinical effects after SI and the adjunctive use of systemically administered (SA) AMX (amoxicillin) + MET (metronidazole) (administered for 7 days), with locally delivered (LDD) piperacillin + tazobactam in step 2 of periodontal therapy. Results: Overall, all parameters were improved in the groups, with a significant difference in inter-group comparison regarding the full-mouth bleeding score (FMBS) (p < 0.05) in favor of the SA group, and the p-value < 0.05 was considered to be statistically significant. Statistically significant PPD (probing pocket depth) reductions and CAL (clinical attachment level) gains were observed in both groups at the 3-month follow-up. In conclusion, within the limitations, the outcomes of this study suggest that SI, with adjunctive local or systemic antibiotic therapy, provided comparable clinical improvements. Systemic AMX + MET protocols were more efficacious with regard to the reduction in FMBS. Follow-up studies with larger patient numbers are needed to further investigate this effect. Full article
Show Figures

Figure 1

14 pages, 4279 KiB  
Article
Profiling Antibiotic Susceptibility among Distinct Enterococcus faecalis Isolates from Dental Root Canals
by Daniel Manoil, Ender Efe Cerit, Hong Fang, Stéphane Durual, Malin Brundin and Georgios N. Belibasakis
Antibiotics 2024, 13(1), 18; https://doi.org/10.3390/antibiotics13010018 - 24 Dec 2023
Cited by 3 | Viewed by 2772
Abstract
Enterococcus faecalis, a leading multi-resistant nosocomial pathogen, is also the most frequently retrieved species from persistently infected dental root canals, suggesting that the oral cavity is a possible reservoir for resistant strains. However, antimicrobial susceptibility testing (AST) for oral enterococci remains scarce. [...] Read more.
Enterococcus faecalis, a leading multi-resistant nosocomial pathogen, is also the most frequently retrieved species from persistently infected dental root canals, suggesting that the oral cavity is a possible reservoir for resistant strains. However, antimicrobial susceptibility testing (AST) for oral enterococci remains scarce. Here, we examined the AST profiles of 37 E. faecalis strains, including thirty-four endodontic isolates, two vanA-type vancomycin-resistant isolates, and the reference strain ATCC-29212. Using Etest gradient strips and established EUCAST standards, we determined minimum inhibitory concentrations (MICs) for amoxicillin, vancomycin, clindamycin, tigecycline, linezolid, and daptomycin. Results revealed that most endodontic isolates were susceptible to amoxicillin and vancomycin, with varying levels of intrinsic resistance to clindamycin. Isolates exceeding the clindamycin MIC of the ATCC-29212 strain were further tested against last-resort antibiotics, with 7/27 exhibiting MICs matching the susceptibility breakpoint for tigecycline, and 1/27 reaching that of linezolid. Both vanA isolates confirmed vancomycin resistance and demonstrated resistance to tigecycline. In conclusion, while most endodontic isolates remained susceptible to first-line antibiotics, several displayed marked intrinsic clindamycin resistance, and MICs matched tigecycline’s breakpoint. The discovery of tigecycline resistance in vanA isolates highlights the propensity of clinical clone clusters to acquire multidrug resistance. Our results emphasize the importance of implementing AST strategies in dental practices for continued resistance surveillance. Full article
Show Figures

Figure 1

Back to TopTop